ABSTRACT
Nasal tumours account for 0.2-0.8 per cent of all tumours. They are two or three times more frequent in males, are rare in infants and increase in incidence after 35 years, reaching their peak between the fifth and seventh decades.1
Over the past decade, the role of the endoscopic sinus surgeon, as well as the concept of a multidisciplinary team,2 has expanded what can be achieved in the management of diseases in the nose, paranasal sinuses and skull base. Advances in endoscopic instrumentation, along with imaging and surgical experience in the endoscopic repair of large skull base defects, have all opened up new and exciting possibilities.3
